MobiLIFE is the supplier of a range of compounded products to public and private hospitals across Australia. Australian owned and operated, it commenced as a medical device supplier in 2002 before developing a product range to include compounded antibiotics, analgesics and a portable infusion device “mobiFUSER™ from its TGA accredited facility in Morisset NSW.
Last year, Slade Health entered an agreement with mobiLIFE to acquire mobiLIFE’s compounding business, including its TGA facility in Morisset. With the transaction now complete the mobiLIFE team has joined Slade Health (part of Icon Group). The purchase of mobiLIFE’s compounding business enables Slade Health to offer a wide range compounded products, now including antibiotics and reflects Slade’s ongoing commitment to providing a complete range of TGA licensed sterile compounding services.
MobiLIFE has retained its Clinical Trial business (and Sydney facility) and its Medical Device (The mobiDRIP).
For more information, please visit the below links: